De novo donor-specific HLA antibodies are associated with early and high-grade bronchiolitis obliterans syndrome and death after lung transplantation.
about
Lung transplantation at DukeThe Influence of Immunosuppressive Agents on the Risk of De Novo Donor-Specific HLA Antibody Production in Solid Organ Transplant RecipientsThe impact of pre-transplant allosensitization on outcomes after lung transplantation.Lung Transplantation in Cystic Fibrosis: Trends and Controversies.Antibody-mediated Rejection in Lung Transplantation.Autologous and Allogenous Antibodies in Lung and Islet Cell Transplantation.Development of a Multivariate Prediction Model for Early-Onset Bronchiolitis Obliterans Syndrome and Restrictive Allograft Syndrome in Lung Transplantation.Clinically relevant interpretation of solid phase assays for HLA antibody.The Role of Humoral Alloreactivity in Liver Transplantation: Lessons Learned and New Perspectives.Antibody-mediated rejection across solid organ transplants: manifestations, mechanisms, and therapies.De Novo DQ Donor-Specific Antibodies Are Associated with Chronic Lung Allograft Dysfunction after Lung Transplantation.IgM-Enriched Human Intravenous Immunoglobulin-Based Treatment of Patients With Early Donor Specific Anti-HLA Antibodies After Lung Transplantation.Characteristics of Donor-Specific Antibodies Associated With Antibody-Mediated Rejection in Lung Transplantation.Antibody-Mediated Rejection in Lung Transplantation: Clinical Outcomes and Donor-Specific Antibody Characteristics.Prevention of chronic rejection after lung transplantation.Acute rejection.Zbtb7a induction in alveolar macrophages is implicated in anti-HLA-mediated lung allograft rejection.Detection and clinical impact of human leukocyte antigen antibodies in lung transplantation: A systematic review and meta-analysis.Blood Gene Expression Predicts Bronchiolitis Obliterans Syndrome.The impact of screening method on HLA antibody detection before and after lung transplantation: A prospective pilot study.Incidence, Characterization and Impact of Newly Detected Donor Specific Anti-HLA Antibody in the First Year after Pediatric Heart Transplantation: A Report From the CTOTC-04 Study.Impact of human leukocyte antigen mismatch on lung transplant outcome.Proteasome Inhibitor Carfilzomib-Based Therapy for Antibody-Mediated Rejection of the Pulmonary Allograft: Use and Short-Term Findings.Complement-activating donor-specific anti-HLA antibodies and solid organ transplant survival: A systematic review and meta-analysis.New frontiers in immunosuppression.
P2860
Q26748519-EE394BC7-FDBA-49C6-BCF3-849BD9B99385Q26774993-84744F4B-7840-4002-8058-230F3865B33EQ36202595-5E15077B-E2FF-4C6C-8093-AEC4C45725E6Q36388454-4DBEADDB-3CD7-4191-9FB4-9147606A20D2Q37441785-71E155B5-2D65-4B2B-8A26-79E56C94561DQ37528715-3A9C9766-A0BE-46D6-B653-B86D65083D60Q38645350-2F705277-98C5-4562-A302-9B25BD2F8DE0Q38839248-60F24125-78BA-43BD-BCB1-CEC4C28A7C15Q39121357-1445C83B-36D0-4FA7-9790-E4E2EE8D9F4BQ39366396-567F163F-737D-46E1-A755-CBDA98A8EB59Q39928595-8C685FEB-5608-475B-B672-858107A260A2Q42364236-69166E70-D9EF-4768-85B7-FDEB3BFA3F67Q42700183-304CD04A-E9D1-4E63-98EE-0AFC54AA9D8DQ44425562-FFC546EF-C759-42AF-9272-FEC3CB3C1E74Q47662940-3A26D8AD-E24E-4700-A047-652AD8918434Q47744928-EF6DF794-3B6F-4603-91ED-E88CF8F4DBA4Q47999795-2F5B8582-1F31-4A7C-AE0A-07DBB841CCA6Q48231169-6BC77D66-3686-4CE9-BF13-F3D504F2B598Q49630908-8E4748A6-989F-4944-BEE4-52FBA820AF14Q49923197-938962A6-E8E5-412B-9A65-BE53541B55DCQ50015757-CC8367E5-792A-413A-9353-AECCD615ADCAQ50193535-303979A6-F04B-4763-931B-A20E3D923CC1Q52793674-5C9BF1FE-5283-4F6D-9113-D909948D95E2Q54969814-EF327A93-576A-4752-A221-1A6C1883D606Q55547403-E3554C92-90A5-4C1C-A53A-32B82DA923F6
P2860
De novo donor-specific HLA antibodies are associated with early and high-grade bronchiolitis obliterans syndrome and death after lung transplantation.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
De novo donor-specific HLA ant ...... th after lung transplantation.
@en
De novo donor-specific HLA ant ...... th after lung transplantation.
@nl
type
label
De novo donor-specific HLA ant ...... th after lung transplantation.
@en
De novo donor-specific HLA ant ...... th after lung transplantation.
@nl
prefLabel
De novo donor-specific HLA ant ...... th after lung transplantation.
@en
De novo donor-specific HLA ant ...... th after lung transplantation.
@nl
P2093
P921
P1476
De novo donor-specific HLA ant ...... th after lung transplantation.
@en
P2093
Christian A Bermudez
Christopher R Ensor
Cynthia J Gries
John F McDyer
Jonathan D'Cunha
Joseph M Pilewski
Maria M Crespo
Matthew R Morrell
Matthew R Pipeling
Norihisa Shigemura
P304
P356
10.1016/J.HEALUN.2014.07.018
P577
2014-08-23T00:00:00Z